Diffuse%20large%20B-cell%20lymphoma
Showing 9951 - 9975 of >10,000
COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)
Active, not recruiting
- COVID-19
- Vaccine Reaction
- LYB001
- CoronaVac
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Characterization of Familial Myopathy and Paget Disease of Bone
Recruiting
- Muscle Disorder
- Bone Disorder
- Diffuse Optical Spectroscopy
-
Irvine, CaliforniaBeckman Laser Institute Medical clinic
Apr 1, 2021
Clostridium Difficile Infection Trial in Canada, United States (Comparison between GenePOC PCR and Reference Method)
Completed
- Clostridium Difficile Infection
- Comparison between GenePOC PCR and Reference Method
-
Indianapolis, Indiana
- +6 more
Apr 29, 2021
Systemic Scleroderma Trial in Duarte (procedure, drug, radiation)
Recruiting
- Systemic Scleroderma
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 7, 2022
Testing of Identification Markers for Stroke
Recruiting
- Stroke, Ischemic
- +2 more
- POCKiT diagnostics' algorithm for LVO detection
-
Birmingham, Alabama
- +2 more
Apr 19, 2022
Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)
Active, not recruiting
- Langerhans Cell Histiocytosis
-
Phoenix, Arizona
- +14 more
Mar 28, 2022
Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Lung Cancer
- BMS-986012
- +4 more
-
Barcelona, Spain
- +3 more
Apr 25, 2022
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Frailty, Childhood Cancer Trial in Memphis (Dasatinib plus Quercetin, Fisetin)
Recruiting
- Frailty
- Childhood Cancer
- Dasatinib plus Quercetin
- Fisetin
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 8, 2022
Morbimortality of Covid-19 in Chronic Inflammatory Rheumatism
Terminated
- Sars-CoV2
- +2 more
- questionnaire assesment
-
Lille, FranceLille University Hospital
Feb 7, 2022
AML Trial in Hangzhou (NKG2D CAR-NK)
Recruiting
- AML
- NKG2D CAR-NK
-
Hangzhou, Zhejiang, China
- +1 more
Feb 17, 2023
Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)
Not yet recruiting
- Advanced Primary Liver Cancer
- IBR900 combined with Lenvatinib
- IBR900 combined with Bevacizumab
- (no location specified)
Jun 6, 2022
Visualizing Beta Cells After Bariatric Surgery
Recruiting
- Type 2 Diabetes Mellitus
- 68Ga-exendin PET/CT
-
Arnhem, Gelderland, Netherlands
- +1 more
Jun 16, 2022
Blood Vessel Study
Completed
- Cardiovascular Disease
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 25, 2023
Patient Acceptance of Health Care, Acute Renal Failure Trial (Clinical decision support, Will not receive Clinical Decision
Not yet recruiting
- Patient Acceptance of Health Care
- Acute Renal Failure
- Clinical decision support
- Will not receive Clinical Decision Support
- (no location specified)
Jun 26, 2023
Refractory Metastatic Colorectal Cancer Trial in Hangzhou (NKG2D CAR-NK)
Recruiting
- Refractory Metastatic Colorectal Cancer
- NKG2D CAR-NK
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Jan 16, 2022
Perioperative Transfusion Strategies in Adult Congenital Heart
Not yet recruiting
- Congenital Heart Disease
- +3 more
- Cardiac surgery in grown-up congenital heart disease patients
-
Brussels, BelgiumCHU Brugmann
Mar 31, 2022
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Suspended
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Short-Term Fasting
- Chemotherapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)
Recruiting
- Urothelial Carcinoma
- Zilovertamab vedotin
-
Cleveland, Ohio
- +11 more
Jan 25, 2023
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022